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2SUMMARY
Elongating RNA polymerases (RNAPs) can interfere with transcription from downstream 
promoters by inhibiting DNA binding by RNAP and activators. However, combining quantitative 
measurement with mathematical modelling, we show that simple RNAP elongation cannot produce 
the strong asymmetric interference observed between a natural face-to-face promoter pair in 
bacteriophage lambda. Pausing of elongating polymerases over the RNAP binding site of the 
downstream promoter is demonstrated in vivo, and is shown by modelling to account for the 
increased interference. The model successfully predicts the effects on interference of treatments 
increasing or reducing pausing. Gene regulation by pausing-enhanced occlusion provides a general
and potentially widespread mechanism by which even weak converging or tandem transcription, 
either coding or non-coding, can bring about strong in cis repression.
3INTRODUCTION
Widespread transcription of non-coding and/or antisense RNA has been found in the genomes of 
bacteria, yeast, Drosophila, Arabidopsis, mouse, and humans (Havilio et al., 2005; Johnson et al., 
2005), and the thorough study of 1% of the human genome by the ENCODE pilot project has
revealed that complex intercalated transcription is no rare peculiarity but the usual state of the 
genome (The ENCODE Project Consortium, 2007). There has also been an increasing appreciation 
that these transcripts possess regulatory functions (Katayama et al., 2005; Prasanth and Spector, 
2007) and are often developmentally regulated (Wilhelm et al., 2008). Though a diverse range of 
functions and mechanisms have been uncovered, the largest class of non-coding RNAs are long 
transcripts of unknown function (Ponting et al., 2009), which are often antisense to coding 
transcripts (Katayama et al., 2005; Wilhelm et al., 2008). Transcriptional interference (TI), defined 
as the suppressive influence of one transcriptional process, directly and in cis, on a second 
transcriptional process (Shearwin et al., 2005), is a proven regulatory role for some of these 
transcripts, and may well be expected to explain the function of a significant fraction more (Bird et 
al., 2006; Callen et al., 2004; Hongay et al., 2006; Martens et al., 2004; Petruk et al., 2006) .
TI can occur between convergent (face-to-face), tandem (co-directional), or overlapping 
arrangements of promoters, where the association and elongation of RNA Polymerases (RNAPs) 
from one promoter disrupts RNAPs and/or transcription factors at a second promoter. TI provides a 
clear evolutionary benefit by diversifying the range of functions of transcriptional regulators, 
permitting repressors and activators of one promoter to indirectly activate or repress a second 
promoter through the alleviation or enforcement of TI (Callen et al., 2004; Martens et al., 2005). 
Numerous studies of in cis TI in eukaryotes and prokaryotes have arrived at a model where the 
elongation of RNAP over a target promoter causes TI by displacing and preventing the binding of 
RNAP or transcription factors to the promoter (Adhya and Gottesman, 1982; Bird et al., 2006; 
4Callen et al., 2004; Greger et al., 1998; Henderson et al., 1989; Martens et al., 2004). In our 
previous work we developed a mathematical model of TI by RNA polymerase traffic in E. coli, 
which demonstrated that ‘occlusion’, prevention of RNAP and activator binding by the passage of
elongating RNAPs through a promoter, is incapable of generating a substantial quantity of TI unless 
either the interfering promoter initiates RNAPs at an extraordinarily rapid rate, or is at least 10
stronger than the target promoter, whose kinetic properties must be attuned to maximise 
vulnerability to TI (Sneppen et al., 2005). Thus, in our current mechanistic understanding of TI, 
substantial transcriptional interference can only arise in the action of a strong promoter upon a weak 
promoter.
To further study the mechanisms of action of TI, our model system is the well characterised PR and 
PRE promoter pair from bacteriophage , where a face-to-face arrangement (separated by 320bp) 
and preliminary measurements suggest the presence of TI (Schmeissner et al., 1980; Ward and 
Murray, 1979). While PR is constitutive, PRE is dependent upon the tetrameric transcriptional 
activator CII. (Shih and Gussin, 1984).
In this combined in vivo and in silico study of TI between PR and PRE, experimental measurements 
of TI were made by -galactosidase assays of LacZ reporter constructs, and mathematical 
modelling of TI was performed with stochastic simulations. We show in vivo that PR strongly 
interferes with PRE but not vice-versa, and that this asymmetric strong TI is inexplicable by our 
previous mechanistic understanding. We go on to show that this strong interference is attributable to 
a mechanism that can allow a weak promoter to exert TI, pausing-enhanced occlusion, where 
pausing of RNAP while positioned over a downstream promoter strongly inhibits transcription.
RESULTS
5Induction of PRE by CII and measurement of PR and PRE transcription 
Transcription from PR and PRE was assayed using a single copy, chromosomal lacZ transcriptional 
fusion system (Figure 1A, Supplemental Figures S1 and S2), inserting a 507 bp fragment of the 
genome in different orientations to measure either PR or PRE. This reporter system bears an RNase 
III cleavage site between the promoter fragment and lacZ, which has been demonstrated to ensure
that lacZ message stability and translation is independent of the sequence upstream of
cleavage(Linn and St Pierre, 1990). Accordingly, LacZ activity is specifically measuring 
interference occurring at the level of transcription.
Between PR and PRE lies cro, a transcriptional repressor of PR. To avoid the complications of this
negative feedback, the helix-turn-helix motif of cro was mutated (YQER), rendering the protein 
unable to bind DNA (data not shown). Also located between PR and PRE is tR1, a Rho-dependent 
terminator of PR transcription. Rho termination factor binds to the nascent RNA at the rut sequence 
and leads to transcription termination at a cluster of three sites collectively termed tR1 (Banerjee et 
al., 2006; Lau et al., 1982). The lambda antiterminator protein, N, blocks termination at tR1 by 
binding to the nut site in the nascent RNA and competing with Rho binding (Vieu and Rahmouni, 
2004)(Figure 1A). To investigate the termination efficiency of tR1, a shortened PR-lacZ reporter 
was constructed, entirely lacking cro, tR1, and PRE, such that comparison to full length reporters 
indicated the efficiency of termination.
The effects of TI on both PR and PRE were measured over a range of PRE activities, by the use of an 
IPTG inducible CII expression system. cII was encoded on a plasmid under the control of pLac, 
while a second plasmid expressed lacI constitutively from pLacI (Figure 1A). Measurements of 
non-interfered promoter activity were obtained for PRE by mutagenesis of the -10 hexamer of PR
(400-fold reduction in LacZ units), and for PR by replacing CII expression vector with empty 
vector, leaving PRE inactive.
6PRE.(PR
–) demonstrates sigmoidal activation of PRE with respect IPTG (Figure 1B). Curiously, this 
sigmoid has a Hill coefficient of 5.1 (Figure 1B); since CII binds PRE as tetramers, this number 
should not exceed 4 for PRE versus CII. Western blotting of cells expressing CII under this IPTG-
inducible system revealed an upward nonlinearity in CII versus IPTG (Figure 1C, D). Using this 
data to transform x-coordinates from IPTG to CII, revealed that the Hill coefficient with respect to 
CII is 3.1 (Figure 1E), within the expected range for the CII tetramer.
Transcription from PR severely interferes with PRE
Comparison of PRE.(PR
+) and PRE.(PR
–) constructs demonstrated that convergent transcription from 
PR reduced PRE transcription 5.5-fold, while the overall shape of the sigmoidal activation curve is 
altered in neither Hill coefficient nor IPTG concentration required for 50% of maximum 
transcription (EC50) (Figure 2A).
Transcription from PRE does not substantially interfere with PR
Measured in the absence of CII, and with lacZ positioned downstream of tR1, PR.(PRE
+) produced
380 LacZ units, which by comparison to the shortened PR lacZ construct (PR (short): 1100 LacZ 
units), indicates 66% termination at tR1, comparable to a previous in vivo measurement of 75% 
(Graham, 2004).
Although transcription from PR was observed to decrease 1.5-fold with CII activation of PRE, IPTG 
induction of CII similarly produced a decrease in transcription from PR (short) and also a reporter of 
the constitutive pBla promoter (Figure 2B). As both the PR (short) and pBla constructs lack CII 
binding sites or a convergent promoter, it appears that CII expression indirectly influences LacZ 
production; this is unsurprising given the known toxic effect of CII on host DNA replication 
(Kedzierska et al., 2003). IPTG alone had no effect (data not shown). Whether the reduction of PR is 
indirect or due to PRE, the TI of PR by PRE is less than or equal to 1.5-fold, a minor effect. 
7Development of a mathematical model of transcriptional interference between PR and PRE
Previous work in this laboratory developed a mathematical model of TI by RNA polymerase traffic 
in E.coli, with analytical, stochastic, and numerical mean-field implementations (Sneppen et al., 
2005). This model describes the interference of a constitutive promoter by a stronger constitutive 
promoter, which itself is unaffected by the interaction. In the case of PR and PRE, the similar 
promoter strengths and mutual interference render the analytical and mean-field models 
inapplicable (Sneppen et al., 2005), leaving the stochastic model, which was adapted to incorporate 
an activator dependent promoter (PRE) and a unidirectional terminator (tR1). 
The stochastic simulation of TI is a discrete time monte carlo, with time steps dt = (RNAP 
elongation velocity)–1, such that elongating RNAPs advance a single base pair per time step. We 
model RNAP initiation with three steps: reversible binding of RNAP to DNA to form a closed 
complex, isomerisation of closed complexes to open complexes, and initiation of elongation by 
open complexes (Supplemental Figure S3). Binding of RNAP to DNA is treated as an equilibrium 
process acting on a faster timescale than promoter firing, and is thus governed by the equilibrium 
binding constant, KB, of RNAP to DNA; binding of CII to DNA is treated similarly. Isomerisation 
of closed to open complexes, and initiation of elongation by open complexes are governed by rate 
constants kco and koe, respectively. These steps received stochastic treatment; occurring with 
probability k.dt per time step, where k is the relevant rate constant. Parameters values are addressed 
in the Supplemental Data.
Before considering transcriptional interference, the model must reproduce CII activation of PRE, 
measured by PRE.(PR
–).lacZ (Figure 1B). In vitro studies have shown CII to activate PRE by a 15-
fold increase in KB and a 40-fold increase in kco (Shih and Gussin, 1984). Activation of PRE by CII 
8was thus modelled by increasing KB and kco linearly with respect to CII occupation of PRE. 
Calculating CII occupation of PRE requires measurements of total CII molecules per cell as a 
function of IPTG (Figure 1C, D), the free energy change of CII tetramerisation, and the affinity of 
CII for DNA. The affinity of CII for DNA is obtained from the measurement that PRE is 50% 
activated at 3100 CII molecules per cell (KD = 3.7M monomers; from Figure 1E). The free energy 
change of tetramerisation is the only unknown parameter, which must be fitted to produce the 
measured Hill coefficient: the best fit to PRE.(PR
–) data is obtained at G = –22.5 kcal/mol, which 
compares remarkably well with an in vitro measurement of G = –23.5 kcal / mol (Ho et al., 
1982). 
Turning now to TI, the model contains three mechanisms (Figure 3A): occlusion, where elongating 
RNAPs block access to a promoter; ‘sitting duck’ interference, where initiation complexes yet to 
fire from a promoter are removed by elongating RNAPs; and collisions between RNAPs elongating 
in opposite directions. A fourth possible mechanism unique to activator dependent promoters is 
dislodgement of DNA-bound activator by elongating RNAP. This increases the effective 
dissociation rate of the activator and thereby increases the EC50 for activation, but does not alter
promoter activity in the presence of saturating amounts of activator. In the event that an activator’s 
intrinsic dissociation rate is much faster than the rate of dislodgement by RNAP, no effect will be 
seen (Supplemental Figure S4). As PRE is measured to undergo no change in EC50 with TI (Figure
2A), we conclude that this mechanism is not pertinent to PRE, presumably due to rapid CII 
dissociation kinetics.
The modelling of TI (further details in Supplemental Data) was essentially the same as in (Sneppen 
et al., 2005), with the exception that it was assumed here that only one RNAP, rather than both 
RNAPs, is lost (randomly) after a collision event. This assumption is more consistent with recent 
AFM imaging of collided E. coli elongation complexes suggesting that collisions induce 
9backtracking of one RNAP (Crampton et al., 2006). The maximal activities of the PR and PRE
promoters were estimated to be 0.17 and 0.12 initiations/sec, respectively, based on LacZ activities 
compared with a Pbla.lacZ reporter and estimates of Pbla firing rates (Liang et al., 1999). RNAP 
velocity was set at 60 bp/sec and termination at tR1, with probability 66%, was assumed to be 
instant. 
A mathematical model of existing mechanisms of transcriptional interference is unable to 
explain the high interference of PRE by PR
Applying the above quantitative model to TI between PR and PRE, it was found that the interference 
of PRE by PR is inexplicably high. TI can be enhanced by the adjustment of a promoter’s kinetic 
parameters to maximise interference by dislodgement of open complexes; this ‘sitting duck’ 
interference is largest when kco and koe are similar (Sneppen et al., 2005). Upon selecting kinetic 
parameters for PRE that maximise TI, only 2.5 fold interference could be simulated; far short of the 
measured 5.5-fold interference (Figure 3B). 
With the same kinetic parameters, simulated TI of PR by PRE is a reasonable match to experimental 
measurements. The failure of the model to explain the observed TI of PRE suggests that we are 
missing an asymmetric mechanism of TI, which specifically enhances the ability of PR to interfere 
with PRE. 
RNAP from PR pause over PRE
One asymmetry in the interaction of PR with PRE is the presence of the unidirectional, Rho-
dependent terminator tR1. In vitro studies have found termination at tR1 to occur in three clusters
located over the PRE promoter (Lau et al., 1982; Roberts et al., 1991)(Figure 4A), and also that Rho-
10
dependent termination requires pausing at the termination site, allowing time for Rho to travel from 
its binding site rut along the nascent transcript to RNAP to effect termination (Lau et al., 1983; 
Richardson, 2002; Vieu and Rahmouni, 2004). It appeared possible then that in vivo, RNAPs from 
PR pause at tR1, and while so paused occlude the PRE promoter. Indeed, pausing of RNAP from PR
over PRE was confirmed in vivo by potassium permanganate (KMnO4) footprinting, a technique 
able to detect paused elongation complexes by preferentially modifying single stranded DNA
(Figure 4B). Comparison of footprints performed on PR
– and PR
+ templates showed a number of 
bands of increased intensity on the PR
+ templates, at positions which correspond to the three 
termination sites previously identified in vitro.
A mutation which enhances pausing of RNAP over PRE increases transcriptional interference
To further investigate if pausing over PRE is a source of TI, PRE was analysed in the presence of a 
mutation designed to enhance pausing over PRE. Mutations of the Rho-binding site rut of the PR
transcript are known to reduce termination at tR1 (Graham, 2004). Weakening the association of 
Rho and reducing termination at tR1 should result in prolonged occupation of pause sites by RNAP 
from PR, since decreased termination implies that: (1) a larger fraction of RNAP will reach the 
second and third pause sites, and (2) RNAP must be removed from pauses (terminated) less 
frequently by Rho-factor. We introduced a 3bp mutation to Rho utilisation site A (rutA–), which has 
been demonstrated to reduce termination through modulation of Rho-RNA interactions (Graham, 
2004). By LacZ assay of PR, we confirmed that rutA
– reduced termination efficiency, from 66% to 
25%.
In vivo pause durations were measured by performing KMnO4 footprinting (Figure 5A, B),
following the addition of rifampicin, which prevents reinitiation of RNA synthesis (Hatoum and 
Roberts, 2008). Pause signals decay as RNAPs leave the pause site but are not replaced, and the rate 
of loss of the signal gives a measure of pause duration. Scans of pixel intensity down the gel (Figure 
11
5A) clearly show that pausing is only occurring downstream of the rutA sequence. Analysis of the 
most distinctly pR specific pause signals (Figures 4B, 5A) on the wild type template gave pause
durations of 33, 33 and 24 seconds at sites I, II and III, which were extended approximately two-
fold by rutA– (Figure 5B). Analysis of a number of other bands within tR1 also gave increased
pause times on the rutA– template. A second, independent time course experiment (not shown) gave 
similar pause durations on the wildtype template which were extended ~ 1.3 fold by rutA–. These 
results confirm that mutation of the rutA site, and the consequent reduction of termination 
efficiency, prolongs occupation of the pause sites located over PRE. The RNAP pause times 
observed are not unusual: a series of E. coli promoters have shown pauses of similar magnitude 




+) by LacZ assay 
revealed that PR now caused 21-fold TI of PRE (Figure 6A), a major increase in TI relative to
PRE.(PR
+).
‘Occlusion by pausing’ allows the mathematical model of transcriptional interference to 
explain the experimental data
Having experimentally confirmed that RNAPs from PR pause over PRE, and that enhanced pausing 
increases TI, we next examined whether occlusion by paused RNAPs can quantitatively explain the 
experimental data using the mathematical model. The model was modified such that RNAPs from 
PR pause upon arrival at each of the three tR1 pause/termination sites (Figure 4A). At each site the
paused RNAPs prevent RNAP binding to PRE, and face a probability to either terminate or resume 
elongation at each time-step spent paused. Also included is the ability of a trailing elongating 
RNAP to force forward translocation of a leading paused RNAP, as has been observed in E.coli
(Epshtein and Nudler, 2003). Termination probability is defined by the experimentally measured 
efficiency of termination for wildtype (66%) or rutA– (25%), while the probability to spontaneously 
resume elongation is the reciprocal of the ‘dwell time’, or the intrinsic duration of the pause: this 
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parameter is unknown and was fitted to experimental data (below). The intrinsic duration of the 
pause is the average time that an RNAP would spend at a pause site in the absence of termination or 
trailing polymerases. In practice, RNAPs will pause for less time than this ‘intrinsic’ pause 
duration, as pauses will be ended prematurely by either termination or forward translocation by a 
trailing RNAP.
Simulated TI of PRE is seen to increase substantially with increasing intrinsic pause time, while 
PR.(PRE
+).lacZ is a reasonable match to experiments with or without RNAP pausing (Figure 3B). 
The greatest increase in TI of PRE is seen in the presence of rutA
–, as decreased termination 
efficiency means that RNAP tend to remain paused for longer. Simulated TI of PRE reaches an
asymptote at large intrinsic pause duration, when the probability of spontaneous re-initiation is 
insignificant relative to the probability of either undergoing termination or of being ‘pushed’ by a 




agree with experimental measurements (Figure 6A). That this asymptote occurs at intrinsic pause 
durations greater than 20 seconds is in strong agreement with experimentally measured pause 
durations greater than 30 seconds.
Recalling that pushing by trailing RNAPs causes pauses to be shorter than either intrinsic pause 
duration or pausing measured in the presence of rifampicin, simulations in the asymptotic case 
reveal that average RNAP pause times are only 5 seconds, distributed across all three sites. It is 
striking that 5 seconds of pausing per RNAP is able to quantitatively explain the 5.5-fold 
interference observed for PRE.(PR
+).lacZ, while in the case of PRE.(rutA
- PR
+).lacZ, average RNAP 
pause times of 8 seconds can explain the measured 21-fold repression.





+); by the adjustment of a single parameter: pause 
13
duration (Figure 6A). This fit is not ‘fine-tuned’, but is satisfied by any pause times greater than 20 
seconds, a requirement met by experimentally measured in vivo pause durations. These conclusions 
are not adversely affected by a different assumption about pushing by trailing polymerases. In the 
absence of pushing, the model simply selects lower intrinsic pause times because the intrinsic rate 
of escape through the pause must increase to make up for the lack of push-through. The consequent 
decrease in pause half-life for a single RNAP at a specific site is compensated by the fact that when 
it moves on, it is replaced by the trailing RNAP. 
An obvious additional experimental test of the occlusion by pausing model is provided by 
considering the effect of a reduction in pausing.
Reduction of pausing by N reduces interference of PRE
The regulatory  protein N competitively binds PR transcripts in place of Rho-factor, and renders 
the elongating RNAP both termination and pause resistant (Mason et al., 1992). In a model lacking 
occlusion by pausing, a reduction in termination by N is predicted to increase “normal” occlusion 
by elongating RNAP and increase TI (Figure 6B). Alternatively, if PRE is occluded by paused 
RNAP, then rendering RNAP from PR pause resistant should decrease the TI of PRE. To test these
competing predictions, PR and PRE were measured in the presence of constitutive chromosomal
expression of N. This reduced the termination of PR transcription at tR1 to 23%, from which it was 
inferred that approximately half of RNAP are N-modified (Supplemental Data). Measurement of 
PRE.(PR
–) showed no influence of N upon PRE in the absence of TI, as expected. Simulations in 
which 50% of RNAP from PR were N-modified, and neither paused nor terminated at tR1, produced 
a 38% increase in PRE activity in the presence of occlusion by pausing, or a 13% decrease in PRE if
occlusion by pausing was not present. Experimentally, PRE.(PR
+ N+) was 27% stronger than
PRE.(PR
+), confirming the prediction that if paused RNAP occlude PRE, reduced pausing should 
reduce TI (Figure 6B).
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Pausing of RNAP can generate strong occlusion of activator or RNAP binding sites
Transcription has been shown to interfere both with promoter activity and activator binding at sites 
distal to a promoter (Adhya and Gottesman, 1982; Bird et al., 2006; Callen et al., 2004; Greger et 
al., 1998; Henderson et al., 1989; Martens et al., 2004). However, strong repression by the passage 
of elongating RNAPs requires a very high interfering transcription rate, or RNAP flux (Callen et al., 
2004; Sneppen et al., 2005). Our study of PR and PRE shows that TI can be augmented by the 
pausing of RNAP while passing over a promoter; a result which can in principle also apply to 
transcription factor binding sites.
An analytical model was constructed to investigate the effect of RNAP elongation and pausing on 
the availability of a downstream transcription factor binding site (Figure 7A). Considering a 10 bp 
operator, with a 30 bp long RNAP elongating at a rate of 60 bp/sec, each RNAP occludes the 
operator for less than 0.7 seconds, and thus even brief pauses can substantially increase occlusion
(Figure 7B). In the absence of pausing, very little occlusion ( 40%) can be generated even with a
flux as high as 1 RNAP per second, while occlusion increases steeply with pause duration even for 
fluxes as low as 1 RNAP every 20 seconds. If an operator can be occluded by adjacent, non-
overlapping pause sites, the fold-interference will be squared: this tactic appears to be utilised at tR1 
to obtain strong repression of PRE with brief pauses.
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DISCUSSION
When maximally activated by CII, the PRE promoter reaches 60% of the constitutive strength of
PR, positioned 320 bp downstream. Transcriptional interference (TI) between these convergent 
promoters produces no more than a 1.5-fold reduction in PR activity, but reduces transcription from 
PRE 5.5-fold. This strong and asymmetric interference is inconsistent with a computational model of 
TI which predicts moderate mutual TI by the mechanisms of (1) collisions between elongating 
RNAP, (2) initiation complex dislodgement and (3) promoter occlusion by elongating RNAP. Our 
acquisition of quantitative data and the use of modelling allowed us to identify a discrepancy 
between theory and experiment, which demanded a reconsideration of the mechanisms of TI. In 
vivo footprinting confirmed past in vitro observations: that RNAP from PR repeatedly pause over 
PRE in the process of Rho-dependent termination at tR1. Rho-binding site mutations were shown to
enhance pausing, and dramatically increased TI of PRE to 21-fold. Expression of the N 
antiterminator protein, known to reduce RNAP pausing at tR1 (Mason et al., 1992), partially 
alleviated TI of PRE. These findings strongly support a new mechanism of TI, occlusion by pausing,
in which RNAPs pause over a promoter and sterically hinder the association of RNAP and/or 
transcription factors. When the experimentally measured RNAP pausing over PRE is introduced to 
the model, it quantitatively explains all experimental observations.
Though other biological functions for pausing have been described (Landick, 2006; Margaritis and 
Holstege, 2008), repression of transcription initiation is a new role. Occlusion by paused RNAP
provides a mechanism by which the manner of transcription elongation, and by extension 
elongation regulatory factors, can directly and potently influence the expression of genes encoded 
on a different transcript. Theoretical analysis of other mechanisms of TI (Sneppen et al., 2005)
(Figure 3A), namely collisions, occlusion by elongating RNAP, dislodgement of transcription 
factors and RNAP (sitting duck), indicates that: (1) adjustment of the quantity of the TI requires 
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changes to a promoter’s activity or kinetic parameters, (2) these mechanisms have a maximal TI
that depends upon the strength of the interfering promoter, and (3) extremely strong promoters are 
necessary to generate more than about 3-fold interference. In contrast, occlusion by pausing can 
potentially be tuned to any quantity of TI by adjustment of pause duration; demonstrated here by an 
increase from 5.5 to 21-fold repression due to a doubling of pause times. Since the quantity of 
repression can be widely tuned, independently of promoter activity or kinetics, occlusion by 
pausing is a powerful and readily evolvable mechanism.
Transcription of antisense or noncoding RNAs has been recently appreciated as a common 
mechanism of repression. In most eukaryotes these noncoding RNAs can repress their target 
transcripts with greater than 1:1 efficiency through the catalytic machinery of RNA interference 
(RNAi). Yet in organisms lacking RNAi such as prokaryotes and S. cerevisiae, intergenic and 
antisense transcription still appears to be a powerful and frequently utilised means of gene 
regulation, pointing to the existence of other mechanisms (Shearwin et al., 2005). Direct TI, 
occurring in cis by the passage of RNAP across the binding sites of activators and/or RNAP at 
another promoter, has been observed in bacteria, yeast, flies, HIV and mouse (Adhya and 
Gottesman, 1982; Bird et al., 2006; Callen et al., 2004; Greger et al., 1998; Henderson et al., 1989; 
Hongay et al., 2006; Martens et al., 2004; Petruk et al., 2006). We have shown here, in agreement 
with past work, that strong occlusion of activator and/or RNAP binding sites cannot be obtained 
even with a very high flux of elongating RNAP (Callen et al., 2004; Sneppen et al., 2005).
However, repression of downstream promoters can be drastically improved by the pausing of 
RNAPs while over activator or RNAP binding sites, producing strong repression with a moderate 
RNAP flux.
How likely is it that occlusion by pausing, which in contrast to direct TI can produce strong 
repression with a moderate RNAP flux, is a widespread mechanism of gene control in higher 
organisms? Several lines of evidence suggest that this may the case. There are many common 
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genetic contexts which are potentially susceptible to occlusion by pausing (Figure 7C). Both basal 
promoters and their associated proximal or distal transcription factor binding sites can be influenced 
by polymerase pausing, as can enhancer sequences, where pausing could cause disruption of 
complexes that activate or repress distant promoters. The transcription which ‘delivers’ the
polymerase may be either convergent or tandem to the interfered promoter, and significantly, this 
transcription may be either coding or non-coding (Ponting et al., 2009; Shearwin et al., 2005). 
Secondly, several studies have shown that at least 85% of eukaryotic genomes are transcribed
(Birney et al., 2007; David et al., 2006) and that there is a large degree of overlapping transcription
(Katayama et al., 2005), suggesting that promoters and their associated elements are likely to be 
subject to considerable passing polymerase traffic. Both single molecule (Adelman et al., 2002; 
Neuman et al., 2003) and bulk in vitro studies suggest that there is an abundance of RNAP pause 
sites in transcribed DNA (Glover-Cutter et al., 2008) and a study of RNA polymerase II dynamics 
in live human cells in culture indicated that a significant fraction of elongating polymerases pause 
for cumulatively long periods (>1 minute) (Darzacq et al., 2007). Given the simple evolutionary 
adjustment required to appropriately locate a pause site, it seems probable that many instances of in 





NK7049 (lacIZYA)X74 galOP308 StrR Su– from R. Simons (Simons et al., 1987) was the host for 
all LacZ assays. DH5 and MC1061 were hosts for recombinant DNA work. Cells were grown at 
37C in Luria Broth with the addition of carbenicillin (100 g/mL for pZS15) and kanamycin (50 
g/mL for pUHA1).
Constructs
Fusions of the region of  containing PR and PRE (: 37954–38461)(Supplemental Figure S1) were 
first formed in the LacZ reporter plasmid pTL61T (Linn and St Pierre, 1990), and then transferred 
to the LacZ reporter phage RS45YA for insertion in single copy into the E.coli chromosome, as 
described in (Dodd et al., 2001) and Supplemental Figure S2. The pBla promoter was amplified 
from plasmid pBR322, in a product extending from -171 to +9, as per (Liang et al., 1999). This 
reporter system bears an RNase III cleavage site between the promoter fragment and lacZ, which 
reduces contextual differences in LacZ translation, and should prevent any antisense RNA 
interactions between PR and PRE transcripts from influencing LacZ activity. When preparing 
reporters of weakly terminated PR.lacZ (PR (short), rutA
– and N+), shuttle strains expressing CI 
protein were used to repress strong LacZ transcription. PR
–, cro–, and rutA– mutations were 
constructed using Quikchange oligonucleotide mutagenesis (Stratagene).
N expression system
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N was expressed from single copy in the E.coli chromosome in the integrating plasmid pAH162 
(Haldimann and Wanner, 2001), with the bacteriophage 186pR promoter (186: 2656–2784)
transcribing N (: 35383–35016).
CII expression system
CII was expressed from the wild-type pLac promoter on the ampicillin resistant plasmid pZS15, 
which is pZE15 (Dodd et al., 2001) with the colE1 origin replaced by the pSC101 origin (Lutz and 
Bujard, 1997). The wild-type cII gene (: 38357–38662) was inserted into pZS15 downstream of 
pLac, with the intervening sequence containing lacZ up to stop codons at aa 20 and 21, followed 
after 15bp by the pET ribosome binding site AGGAGA to drive efficient CII translation. To control 
CII expression from pLac on pZS15cII, Lac repressor was supplied by pUHA1, a p15A plasmid 
encoding kanamycin resistance and carrying the wild-type lacI gene and promoter, obtained from 
H. Bujard (Heidelberg University, Germany). 
LacZ assays
Kinetic LacZ assays were performed in 96-well microtitre plates by a protocol modified from 
(Dodd et al., 2001). Fresh colonies on selective LB plates were resuspended in LB and used to 
inoculate 200L of selective LB in a 96-well microtitre plate, sealed and incubated overnight at 
37C without shaking. Overnight cultures were diluted into LB in proportion to their density,
approximately 3-fold, before further diluting 2L into 98L of fresh selective LB plus IPTG in a 
microtitre plate. Cultures were incubated with rotation at 37C until OD600 reached 0.65 – 0.75 (log 
phase) and were then assayed for LacZ activity (Dodd et al., 2001).
Western blotting of CII
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Cultures of NK7049 pUHA1 pZS15cII were grown to log phase by the same protocol as for LacZ 
assays. Cultures were resuspended in 1/25th volume B-PER lysis reagent (Pierce) supplemented 
with 0.2 mg/mL fresh lysozyme and 2.5 units of Benzonase (Merck), incubated on ice for 1 hour, 
diluted 1:1 with 2 Novex Tricine SDS sample buffer (Invitrogen), and heated to 85C for 2 
minutes. Pure CII protein was supplied by Pradeep Parrack (Bose Institute, India). For consistency 
of background bands upon western blotting, pure CII protein was added to cII– extract prepared as 
per cII+ extracts, such that for both pure CII and cII+ extracts 5L of cell extract was loaded in a net 
volume of 10L for each lane during electrophoresis. For quantitation of IPTG concentrations 100 –
300M, cII+ extracts were diluted 1.5L into 3.5L of cII– extract.
Membranes were scanned and images analysed by a Typhoon Trio and ImageQuant (Amersham).
Numbers of E.coli cells per sample were determined by measurement of culture density prior to 
harvesting and comparison to colony forming assays.
In vivo permanganate footprinting
In vivo permanganate footprinting was performed on E. coli strain NK7049 carrying pTL61T based 
LacZ reporter plasmids. PRE.(PR
–) and PRE.(PR
+) constructs, containing either a wild type or mutated 
rutA site were used. There was no source of CII in these strains, in order that there was minimal 
transcription from PRE. To determine the location of the presumed pause site(s) of RNAP 
transcribing from PR, plasmid DNA prepared from KMnO4 treated cultures were subject to primer 
extension analysis, as detailed in Supplemental Data.
Stochastic simulations of transcriptional interference
The essential mechanics of the stochastic simulation of TI are described in Results with further 
details in the Supplemental Data. Simulated promoter activities in Figures 2 and 3 are the result of 
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simulating 200 hours of transcription at each point. The program, written in FORTRAN, is 
available on request.
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FIGURE LEGENDS
Figure 1. Activation of PRE by IPTG induction of CII.
(A) Diagram of single-copy chromosomal lacZ reporter and plasmid system for IPTG regulated 
expression of CII. IPTG regulated expression of CII is achieved with a two plasmid system: 
pUHA1 contains pLacI-lacI and pZS15cII contains pLac-cII. The region of lambda used in the 
reporter system is shown as a thicker line. The relative locations of the Rho utilisation site (rut), N 
utilisation site (nut) and the tR1 terminator are shown. 
(B) Activity of PRE.(PR
–).lacZ (n=12) as a function of IPTG, which induces expression of CII from 
pLac in pZS15cII. Error bars in this and all subsequent figures are 95% confidence limits. The line 
connecting points is the Hill function of best fit. The average Hill coefficient is 5.1 0.4 (95% 
confidence limits).
(C) Western blotting of CII from E.coli pUHA1 pZS15cII grown in a range of IPTG concentrations, 
quantitated against a calibration curve of pure CII protein added to cII– E.coli extracts. For the IPTG 
concentrations 100 to 300M (lower panel), cII+ extracts were diluted 3.3-fold into cII– extracts, to 
give a quantity of CII that lies within the calibration curve. The 100M IPTG point was measured 
in both diluted and undiluted form, giving average measurements within 6% of one another.
(D) Quantitation of CII western blotting, showing the results of three independent sets of western 
blots (filled, open, and grey). Grey circles are the data of (C), and a continuous line shows the 
average of all data.
(E) Activity of PRE.(PR
–).lacZ plotted as a function of CII molecules per cell. Using the western 
blotting of (C) and (D), CII molecules per cell were measured for 7 IPTG concentrations. CII 
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molecules per cell for those IPTG concentrations not directly measured were determined by 
interpolation between measured data. The average Hill coefficient is 3.1 0.3 (95% confidence
limits). Assuming an average cellular volume of 1.4 fL, we can determine from this data that the in 
vivo affinity of CII for its binding site is KD = 3.7 M.
Figure 2. Transcriptional interference between PR and PRE.
(A) Activity of PRE.(PR
–).lacZ and PRE.(PR
+).lacZ (n=14), demonstrating a 5.5-fold repression of PRE
due to TI from PR. Lines are Hill functions of best fit; the fitted EC50s are 78 M IPTG for PRE.(PR–
) and 76 M IPTG for PRE.(PR+).
(B) Activity of PR (short).lacZ (n=6), PR.(PRE
+).lacZ (n=15), and pBla.lacZ (n=10), in response to 
IPTG induction of CII. Only PR.(PRE
+).lacZ contains a CII binding site or CII-activated promoter in 
between the promoter and lacZ.
Figure 3. Simulations of transcriptional interference cannot explain experimental 
observations using existing mechanisms.
(A) Schematic of different mechanisms of transcriptional interference, in which the left (darker) 
promoter is interfering with the right (lighter) promoter.
(B) Alignment of experimental measurements of promoter activity with the existing mathematical 
model of TI. Points are experimental data and lines are the results of stochastic simulations of TI, 
incorporating the mechanisms of occlusion, ‘sitting duck’, and collisions.
Figure 4. RNAP from pR pauses at tR1.
(A) Sequence of tR1 and PRE. Above the sequence the three in vitro pause/termination sites at tR1 
(Lau et al., 1982) are marked, together with the expected protected region for RNAP paused at each 
29
of these pause sites. Below the sequence is marked the binding region for RNAP at PRE, 
demonstrating that RNAP paused at tR1 should sterically hinder the association of RNAP to PRE.
(B) In vivo potassium permanganate footprinting was performed to identify RNAP pause sites at 
tR1, for rutA+ and rutA– templates. To ensure pauses were specific for transcription originating 
from pR, pR+ and pR- templates were compared. Footprints were obtained for both top and bottom 
strands, and run alongside lanes containing dideoxy sequencing reactions which had been generated 
using the same primers (only the A lane is shown). The bands which are the most distinctly pR 
specific are indicated by arrowheads. The indicated bands were observed in several (n=5) 
independent footprint reactions and are consistent with the known three tR1 termination sites 
observed in vitro (indicated at the side of figure).
Figure 5. A rutA mutation extends the lifetime of the pauses
(A) Measurement of pause durations at the three tR1 sites by in vivo permanganate footprinting
following addition of rifampicin. Footprints were obtained for the bottom strand on both rutA+ and 
rutA– templates and run alongside lanes containing dideoxy sequencing reactions which had been 
generated using the same primer (only the A and C lanes are shown). The appearance of a strong pR 
band indicates accumulation of open complexes at pR, showing that rifampicin is blocking further 
rounds of RNA synthesis. In contrast, the tR1 pause signals decay with time, as the paused RNAP 
either terminates or resumes elongation. Plots of pixel intensity down the rutA+ lanes of the gel are 
overlaid for the 15 (blue), 30 (green), 60 (red) and 300 (black) second time points. Black dots 
indicate the pR-specific bands (Figure 4B) which were used for the estimation of pause durations at 
sites I, II and III shown in (B).
(B) The average RNAP pause durations for rutA+ and rutA– templates at each of the three tR1 
pause sites were estimated by plotting the rate of loss of signal with time following addition of 
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rifampicin. The average pause durations, calculated as 1/slope of these plots, are indicated within 
each graph. The intensity of the 15 second time point was used as the initial value, in order to allow
time for pR derived polymerases, which were elongating at the time of rifampicin addition, to reach 
tR1. Average pause durations were consistently increased on the rutA– templates. 
Figure 6. Occlusion by paused RNAP can explain the strong transcriptional interference of 
PRE
(A) Experimental and simulated TI of PRE, in rutA
+ and rutA– conditions, with simulations 
incorporating occlusion by paused RNAP. Points are experimental data: PRE.(PR
–).lacZ (blue), 
PRE.(PR
+).lacZ (red), and PRE.(rutA
– PR
+).lacZ (black) (n=7). PRE.(rutA
– PR
+).lacZ has been scaled 
up to normalise PRE activity in the absence of TI, to facilitate comparison of fold-interference
against rutA+ constructs; this is necessitated by rutA– causing a 27% decrease in PRE LacZ activity 
in the absence of TI. Lines are stochastic simulations of TI: dotted lines are simulations without 
RNAP pausing at tR1, and solid lines are simulations with intrinsic RNAP pause durations at tR1 of 
20 seconds. Marked along the right of the graph are the predicted maximum activities of PRE.(PR
–
).lacZ (red) and PRE.(rutA
– PR
+).lacZ (black) with intrinsic pause durations of 0, 2, 5 and 20+
seconds, illustrating how pausing of RNAP progressively increases repression of PRE. The thickness 
of the 20+ second line spans the range of promoter activity calculated for pause durations from 20 
to 1000 seconds.
(B) As for (A), showing the effects of reduced pausing due to N in green: PRE.(PR+ N+).lacZ
(n=10). Expression of N had no influence upon PRE.(PR–).lacZ (data not shown).
Figure 7. Substantial occlusion can only be obtained with RNAP pausing.
(A) Analytical model of occlusion by RNAP pausing. RNAP with an occlusion length of l bp, 
travelling at velocity v bp / sec, arrive at an operator of length m bp, with flux f (RNAP / second). 
31
The RNAP move to the end of the operator with rate v.(l + m)–1, whereupon they reach a pause site 
and remain paused for an average duration P sec. Thus with rate P–1 the paused state can change to 
a vacant state, or with rate f another RNAP may arrive at the start of the operator. The fraction of 
time the operator is occluded is given by the equation shown. This result is independent of whether 
the pause site is positioned at the start or end of the operator.
(B) Occlusion as a function of pause duration and RNAP flux, calculated for a m = 10bp operator 
being occluded by l = 30bp long RNAPs which elongate at a rate of v = 60 bp/sec.
(C) Genetic arrangements where occlusion by pausing may regulate gene expression.
Transcription may be tandem (upper) or convergent (lower) to the interfered promoter and may be 
either coding or noncoding. Pausing of RNAP over the promoter itself, or over associated elements 
such as transcription factor binding sites (TF) or enhancer sequences, may lead to reduction in 
promoter activity. 
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1SUPPLEMENTAL DATA
Potent transcriptional interference by pausing of RNA polymerases over a 
downstream promoter
Adam C. Palmer, Alexandra Ahlgren-Berg, J. Barry Egan, Ian B. Dodd and Keith E. Shearwin
Modelling the PR-PRE system 
Concentration scales
In order to convert between concentrations and numbers of molecules per cell, the volume of an E. 
coli cytoplasm is required. E. coli are shaped as cylinders with hemispherical ends, with a ratio of 
length to width of 4.4, over a range of growth rates (Donachie and Robinson, 1987). The dry weight 
of an E. coli cell is 6.4 ×10-13 g, and E. coli are 70% water, with a density of 1.05 g/mL (Bremer 
and Dennis, 1996). Therefore the total volume of an E. coli cell is 2.0 ×10-18 m3 (2 fL), by which we 
calculate the cell to be 3.8 μm long and 0.9 μm wide. The volume of the cytoplasm is significantly 
less than 2 fL, as the periplasm occupies some 20% of the total volume of the cell, and making 
further subtractions for the volume occupied by the outer and cytoplasmic membranes (each 8 nm 
thick), the volume of the cytoplasm is estimated to be 1.4 fL (Neidhardt, 1990). In this volume then, 
one molecule is equivalent to a concentration of 1.2 nM. 
CII tetramerization and DNA binding
The data of Figure 1E, showing PRE activity versus CII molecules per cell, was fitted to the 
following reaction scheme: 4CII  CII4 with Ktet (M-3); CII4 + DNA  CII4.DNA with KD (M). PRE
activity was assumed to be proportional to the fractional occupancy of the single binding site for the 
tetramer, and as calculated above, cell volume was taken to be 1.4 fL 
The optimal values were Ktet = 7.3 x 10
15 M-3 monomers (equivalent to G = –22.5 kcal/mol of 
tetramer formed) and KD = 350 nM tetramers. The measured KD of CII tetramers for PRE could not 
F) Supplemental Text and Figures
2be directly used as CII tetramer affinity in the model, since this would not account for the 
cooperative binding between CII and RNAP, measured to improve the RNAP binding 15-fold (Shih 
and Gussin, 1984). Alignment of experimental and theoretical PRE activation curves along the CII 
axis is achieved with a raw KD for CII tetramers of 870 nM, strengthened to 58 nM in the presence 
of cooperative binding to RNAP.
Promoter Kinetics
LacZ units were converted to RNAP initiations per second using the data of (Liang et al., 1999), 
who measured the RNAP initiation rate from the E.coli pBla promoter as a function of growth rate, 
indicating that under the growth conditions of our LacZ assays (doubling time 42 minutes), each 
copy of the pBla promoter initiates 0.021 RNAP / second. Our pBla.lacZ reporter generated 137 
LacZ units, from which we converted LacZ activities for PR and PRE to RNAP initiations per 
second. Maximal PR activity, as measured with the PR (short) reporter lacking tR1, was 0.17 
elongating RNAP per second. PRE ranged from basal (CII
–) activity of 5 10-4 to maximal activity 
(saturated with CII) of 0.12 elongating RNAP per second.
As discussed in the main text, promoter kinetics are characterised by 3 parameters, KB, kco, and koe
(Supplemental Figure S3, Supplemental Table 1). For PRE we have measured both basal and 
activated rates, and KB and kco have been measured to be enhanced 15 and 40 by CII (Shih and 
Gussin, 1984), leaving 1 degree of freedom. This degree of freedom is fixed by selecting ‘aspect 
ratio’ equal to 1, which is the ratio of the rate of open complex formation and rate of initiation by 
open complexes. This choice maximises the modelled vulnerability of PRE to TI, since interference 
by dislodgement of initiation complexes is maximised at aspect ratio 1 (Sneppen et al., 2005). As 
we are demonstrating that the initial model significantly underestimates the interference of PRE by 
PR, our claims are at their most conservative when kinetic parameters maximise interference of PRE.
Dislodgement of initiation complexes makes a significant contribution to TI when an interfering 
3promoter is much stronger than the interfered promoter (Sneppen et al., 2005), and so we expect 
this to make only a minor contribution to interference between PR and PRE, which are of similar 
maximum, non-interfered activities. When kinetic parameters of PRE were changed to reduce aspect 
ratio by 100-fold (KB (CII+) = 0.14, kco (CII
+) = 1.1, koe = 10), simulated interference of PRE by PR, 
with 20 second pause times at tR1, changed from 5.6-fold to 4.6-fold. Therefore, provided that the 
values of KB, kco and koe are set to produce the experimentally measured PRE activity in the absence 
of TI (0.12 RNAP initiations/second), the simulated fold-interference is insensitive to alteration 
throughout KB, kco, koe parameter space. Similarly, simulated interference of PRE and PR is 
insensitive to the specific kinetic parameters of PR; only net RNAP initiation rate is of importance.
Supplemental Table S1. Promoter kinetic parameters
KB kco (s
-1) koe (s
-1) Net RNAP 
initiations / second*
PR   3.3     0.25 100 0.173
PRE (CII
–)   0.018   0.03     0.26 0.0005
PRE (CII
+)   0.27   1.22     0.26 0.123
Activation by CII: 15  40    1  235 
*Calculation of net RNAP initiations / second from the kinetic scheme will result in slightly faster 
rates than those listed here, which are slower to account for ‘self-occlusion’ – an elongating RNAP 




The following characteristics of RNAP were using in the modelling:
4Extent of DNA occupied by initiating RNAP at the promoter complex = +18 to -55 (Metzger et al., 
1989),
Length of elongating RNAP = 30 bp (Epshtein et al., 2003),
Distance from the front of a stalled elongating RNAP to RNA 3’ end = 6 bp (Toulme et al., 2000),
Collision of elongating RNAPs was modelled by instantaneous removal of one RNAP.
RNAP elongation speed
Our previous model of transcriptional interference (Sneppen et al., 2005) estimated RNAP velocity 
to be 40 bp/sec, using data in which changes in the spacing between converging promoters were 
seen to affect interference (Callen et al., 2004). This estimate was based on the assumption that both 
RNAPs are lost in a collision, while here we assume only one RNAP is lost, according to AFM 
imaging of collided E.coli elongation complexes demonstrating that collisions induce backtracking 
of only one RNAP (Crampton et al., 2006). The previous estimate also used a value for the firing 
rate of the interfering promoter obtained from a different calibration of LacZ units versus initiations 
per sec. We prefer our current calibration, which gives a 4-fold higher value for initiations per sec, 
because pBla is more similar in strength to the promoters studied in (Callen et al., 2004) than our 
past reference promoter. Re-evaluation of the spacing-interference data of (Callen et al., 2004) with 
these new assumptions gives a revised estimate for RNAP elongation speed of 60 bp/sec, which is 
used here and is within the range estimates of in vivo RNAP elongation speed obtained by other 
methods (Sneppen et al., 2005).
Modification of RNAP by N 
When an N-modified RNAP passes through tR1, we assumed that it pushes paused, unmodified 
RNAP out of their pauses, and thus saves them from termination. Thus, in our model N both 
abolishes termination of modified RNAP, and also reduces the termination rate of unmodified 
5RNAP. Both mechanisms were taken into account when calculating the percentage of N-modified 
polymerases based on the observed termination frequency.
Supplemental experimental procedures
KMnO4 footprinting in vivo
In vivo permanganate footprinting was performed on E. coli strain NK7049 carrying pTL61T based 
LacZ reporter plasmids. PRE.(PR
–) and PRE.(PR
+) constructs, containing either a wild type or mutated 
rut site were used. There was no source of CII in these strains, in order that there was minimal 
transcription from PRE .To determine the location of the presumed pause site(s) of RNAP 
transcribing from PR, plasmid DNA prepared from permanganate treated cultures were subject to 
primer extension analysis, as follows.
Overnight cultures were subcultured in 40 ml of fresh M9CAA medium (1x M9 salts, 100 M 
CaCl2, 1 mM MgSO4, 0.2% glucose, 2 mg/ml casamino acids, 40 mg/ml thiamine and 100g/ml 
ampicillin) and grown at 37°C to an OD600 of 0.6. KMnO4 was added to the cultures to a final 
concentration of 3 mM and left for 2 or 4 minutes before quenching with an equal volume of ice 
cold STE (50 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA pH 8.0). The bacterial pellets were 
harvested by centrifugation at 6000 g for 25 min at 4°C and then resuspended in buffer P1 (Qiagen 
Miniprep Kit) with RNaseA added to a final concentration of 200 g/ml. DNA was prepared using 
the Qiagen Miniprep Kit according to the standard protocol, with the exception that lysozyme was 
added to a final concentration of 2 mg/ml for 5 min at room temperature before adding 500 l of 
buffer P2 and 700 l of neutralizing buffer N3. DNA was eluted in 10 mM Tris pH 8.0 preheated to 
70°C. 
6To assess the quality and concentration of the DNA preparations, samples were electrophoresed on 
a 0.8 % agarose gel, stained with GelRed (Biotium, CA), and imaged in a Typhoon Trio (GE 
Healthcare). To determine DNA concentrations, gel images were analysed using ImageQuant 5.2 
software, using dilutions of a 2-log ladder (New England Biolabs) to generate a standard curve.
Two oligos were used for primer extension analysis; primer cro-Alex (5’ 
GGAAGCGTTTATGCGGAAGAGG 3’) located in the cro gene facing PRE and primer alt-329 (5’ 
CATGTTTGACAGCTTATCATCGGAGC 3’) facing PR. The oligos were end-labelled using [-
32P]-ATP (Perkin Elmer) and T4 polynucleotide kinase (New England Biolabs) and purified using 
MicroSpin G-25 columns (GE Healthcare). 1.2 pmol of either oligo was used for extension of 15 
fmol of template DNA allowing for at least a 5-fold excess of primer at the end of the reaction. The 
extension reactions were performed in a final volume of 50 l, adding dNTP to a final concentration 
of 200 mM and 5 Units of Taq DNA Polymerase (New England Biolabs). The extension reactions
were run for 15 cycles (95°C 1 min,  57°C  30 sec, 72°C 30 sec) with an initial denaturation step of 
95°C for 5 min. Extension products were dried under vacuum and resuspended in 9 L loading 
buffer (98 % formamide, 10 mM Tris pH 8.0). Dideoxy sequencing reactions were prepared using 
the DNA Cycling Sequencing Kit (Jena Bioscience) using the same [-32P]-ATP end-labelled 
primers. Extension products and sequencing reactions were electrophoresed on 6% polyacrylamide 
gels containing 6M Urea (National Diagnostics) in 1 x TBE (50 mM Tris, 100 mM boric acid and 5 
mM EDTA). Dried gels were imaged by a Typhoon Trio (GE Healthcare) and analysed using 
ImageQuant 5.2 software.
Footprinting reactions performed following rifampicin treatment (0.2 mg/mL) were as described 
above, except that permanganate treatment was for 1 minute using 6 mM KMnO4, and primer 
extensions were carried out using only primer alt-329. Gel bands were quantitated using the volume 
7integration function of Imagequant 5.2. Band intensities were normalised to a group of invariant 
bands upstream of pR to account for any differences in sample loading between lanes.  
Western Blotting
After SDS-PAGE on NuPAGE 16% Tricine (Invitrogen) gels, samples were electrotransferred at 
25V for 2 hours onto Hybond-LFP (Amersham). Immunoblotting was performed as per the ECL 
Plex Western blotting system (Amersham). Primary rabbit antibody to CII, kindly provided by 
Amos Oppenheim (Hebrew University-Hadassah Medical School, Israel), was applied at 1/2000 
dilution following a 1 hour pre-incubation at 37C with a 1/60th volume of 10 concentrated, 
sonicated cII– cell extract. Secondary antibody was Plex Cy-5 anti-rabbit, applied at 1/4000 dilution.
8Supplemental References
Bremer, H., and Dennis, P. (1996). Modulation of chemical composition and other parameters of 
the cell by growth rate. In Escherichia coli and Salmonella typhimurium: Cellular and Molecular 
Biology, F. C. Neidhardt, R. C. III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. 
Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger, eds. (Washington DC, ASM Press), pp. 
1553-1569.
Callen, B. P., Shearwin, K. E., and Egan, J. B. (2004). Transcriptional interference between 
convergent promoters caused by elongation over the promoter. Mol Cell 14, 647-656.
Crampton, N., Bonass, W. A., Kirkham, J., Rivetti, C., and Thomson, N. H. (2006). Collision 
events between RNA polymerases in convergent transcription studied by atomic force microscopy. 
Nucleic Acids Res 34, 5416-5425.
Donachie, W. D., and Robinson, A. C. (1987). Cell Division: Parameter Values and the Process. In 
Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology, F. C. Neidhardt, J. 
L. Ingraham, K. B. Low, B. Magasanik, M. Schaechter, and H. E. Umbarger, eds. (Washington DC, 
ASM Press), pp. 1578-1593.
Epshtein, V., Toulme, F., Rahmouni, A. R., Borukhov, S., and Nudler, E. (2003). Transcription 
through the roadblocks: the role of RNA polymerase cooperation. Embo J 22, 4719-4727.
Lau, L. F., Roberts, J. W., and Wu, R. (1982). Transcription terminates at lambda tR1 in three 
clusters. Proc Natl Acad Sci U S A 79, 6171-6175.
Lau, L. F., Roberts, J. W., and Wu, R. (1983). RNA polymerase pausing and transcript release at the 
lambda tR1 terminator in vitro. J Biol Chem 258, 9391-9397.
Liang, S., Bipatnath, M., Xu, Y., Chen, S., Dennis, P., Ehrenberg, M., and Bremer, H. (1999). 
Activities of constitutive promoters in Escherichia coli. J Mol Biol 292, 19-37.
Linn, T., and St Pierre, R. (1990). Improved vector system for constructing transcriptional fusions 
that ensures independent translation of lacZ. J Bacteriol 172, 1077-1084.
9Metzger, W., Schickor, P., and Heumann, H. (1989). A cinematographic view of Escherichia coli 
RNA polymerase translocation. Embo J 8, 2745-2754.
Neidhardt, F. C., J.L. Ingraham, and M. Schaechter. (1990). Physiology of the Bacterial Cell: A 
Molecular Approach (Sunderland MA, Sinauer Associates).
Powell, B. S., Rivas, M. P., Court, D. L., Nakamura, Y., and Turnbough, C. L., Jr. (1994). Rapid 
confirmation of single copy lambda prophage integration by PCR. Nucleic Acids Res 22, 5765-
5766.
Shih, M. C., and Gussin, G. N. (1984). Role of cII protein in stimulating transcription initiation at 
the lambda PRE promoter. Enhanced formation and stabilization of open complexes. J Mol Biol
172, 489-506.
Sneppen, K., Dodd, I. B., Shearwin, K. E., Palmer, A. C., Schubert, R. A., Callen, B. P., and Egan, 
J. B. (2005). A mathematical model for transcriptional interference by RNA polymerase traffic in 
Escherichia coli. J Mol Biol 346, 399-409.
Toulme, F., Mosrin-Huaman, C., Sparkowski, J., Das, A., Leng, M., and Rahmouni, A. R. (2000).
GreA and GreB proteins revive backtracked RNA polymerase in vivo by promoting transcript 
trimming. Embo J 19, 6853-6859.
10
Supplemental Figures
Supplemental Figure S1. Sequence and features of bacteriophage lambda PR to PRE region.
The -10 and -35 regions of PRM, PR and PRE are shown shaded in green, blue and purple, 
respectively. Protein coding sequences are shown in light blue, and their ribosome binding sites 
(SD) are overlined. The rutA and rutB sequences (between the cro and cII genes), which together 
make the Rho utilisation site (rut) are shown, as are the BoxA and BoxB sequences, which form the
nutR site. 
The PCR primers used to amplify the PR to PRE region for insertion into the XhoI and XbaI sites of 
pTL61T (Linn and St Pierre, 1990) are shown, as are the PR
- and PRE
- mutations, the Cro- amino 
acid changes within the Cro helix-turn-helix motif (HTH), and the three base-pair changes which 
together make the rut- mutation. The three termination sites at tR1 (bases shown in red) are 
indicated as tI, tII and tIII (Lau et al., 1982; Lau et al., 1983). The CII binding site, consisting of 
two direct repeats either side of the PRE -35 sequence are indicated as green lines.
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Supplemental Figure S2. Construction of lacZ reporters
Promoter fragments to be assayed (sequence positions 37954 to 38461) were amplified by PCR 
with the proofreading Pfu DNA polymerase with primers adding XhoI and XbaI ends; 5’ XhoI and 
3’ XbaI for pR to control lacZ, 5’ XbaI and 3’ XhoI for PRE to control lacZ (where 5’→ 3’ is from 
PR towards PRE). These PCR products were ligated into the polylinker of pTL61T; both junctions 
and the insert were checked by sequencing. This was recombined in vivo with the modified lambda 
phage, λRS45YA. Reporter phage were purified and lysogenised in NK7049, and single lysogens 
were isolated (Powell et al., 1994). These lysogens contained a single copy of the reporter fragment 
at the λ attachment site in the E. coli chromosome, with either PR or PRE directing transcription of 
the lacZ gene. Between promoter fragments and the lacZ gene is an RNaseIII cleavage site, which 
causes lacZ RNA to be separated from RNA transcribed within the reporter fragment; this is 
observed to reduce potential context effects from different constructs (Linn and St Pierre, 1990).  
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Supplemental Figure S3. Kinetic scheme of promoters in simulations of TI
PRE is modelled with this full kinetic scheme, while for PR only the top row of states (lacking CII) 
are relevant. KB is the dimensionless equilibrium binding constant of RNAP to a promoter, treating 
RNAP concentration as a constant which is absorbed into the value of KB. kco (sec
–1) and koe (sec
–1) 
are the rate constants for closed to open complex isomerisation, and initiation of elongation from an 
open complex. KD (CII tetramers per cell)–1 is the equilibrium dissociation constant of CII 
tetramers for their binding site at PRE.  = 15 is the fold enhancement of KB in the presence of CII, 
and  = 40 is the fold enhancement of the rate constant for closed to open complex isomerisation
(Shih and Gussin, 1984). As only the slow, non-equilibrium reactions kco and koe are treated
stochastically, this reaction scheme reduces to two irreversible steps: an effective isomerisation rate, 
and the rate of initiation of elongation (koe). For PR the effective isomerisation rate is kco.KB.( 1 + 
KB )–1, while for PRE the effective isomerisation rate is kco.( KB + ..KB.CII4.KD–1 ).( 1 + KB + 
CII4.KD
–1 + .KB.CII4.KD–1 )–1.
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Supplemental Figure S4. Dislodgement of a DNA-binding activator increases the activator’s 
EC50
Simulations are of an activator-dependent promoter, where the activator spans a range of 
association/dissociation kinetics; times listed in legend are (dissociation rate constant)–1. Variable 
speeds of association/dissociation reactions have no effect upon a non-interfered (TI–) promoter, as 
only the equilibrium binding constant, here held constant, influences the EC50. In the presence of 
interference (TI+), slow association/dissociation kinetics leave the promoter vulnerable to 
interference by activator dislodgement, with transcription initiation rate decreasing more with 
slower kinetics. As effective association rate constant increases with activator concentration, the 
effects of activator dislodgement are eventually overcome with a sufficiently high concentration of 
activator, and so TI by activator dislodgement manifests as an increase in EC50, rather than a 
decrease in maximum possible transcription rate.
